Recombinant human C39, also known as ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), encompassing amino acids 38-478. This construct contains a C-terminal His-tag (10xHis). The recombinant protein was affinity purified.
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
MW
52 kDa + glycans
Amino Acids
38-478
Glycosylation
This protein runs at a higher MW by SDS-PAGE due to glycosylation.
Specific Activity
≥3000 pmol/min/μg
Genbank #
NM_001776
UniProt #
P49961
Tag(s)
C-terminal His-tag
Background
CD39 contributes to immune regulation through the hydrolysis of ATP to AMP in the rate limiting step of extracellular adenosine production. CD39 is expressed on the surface of multiple cells of the immune system including T-cells, Natural killer cells, B-cells, dendritic cells and macrophages. In addition, high levels of CD39 expression have been associated with the tumor microenvironment (TME). Research aimed at reducing immunosuppression by CD39 activity has resulted in the study of a small molecule inhibitor, POM1, and multiple anti-CD39 antibodies selected for blocking enzymatic activity or decreasing CD39 expression.
References
1. Deaglio, S. et al., Journal of Environmental Medicine. 2007 Jun 204(6): 1257-1265.
2. Borsellino, G. et al., Blood. 2007 Aug; 110(4):1225-1232.
Storage/Stability
At least 6 months at –80°C
Assay Conditions
Assay was done according to CD39 Inhibitor Screening Assay Kit (BPS Bioscience #79278) with various amounts of CD39.
Instructions for Use
Thaw on ice and gently mix prior to use. DO NOT VORTEX. Perform a quick spin before opening. Aliquot into small volumes and flash freeze for long term storage. Avoid multiple freeze/thaw cycles.
Applications
Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.